Global Molecular Diagnostics for Infectious Diseases Market Growth 2026-2032
The global Molecular Diagnostics for Infectious Diseases market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Molecular diagnostics for infectious diseases involves the detection and analysis of microbial genetic material, such as DNA or RNA, to identify and diagnose infections. This advanced diagnostic approach uses techniques like polymerase chain reaction (PCR), nucleic acid amplification, and gene sequencing to detect the specific genetic signatures of pathogens. Molecular diagnostic tests offer high sensitivity and specificity, enabling the rapid and accurate identification of infectious agents, including bacteria, viruses, fungi, and parasites. These tests play a crucial role in disease diagnosis, monitoring treatment efficacy, and guiding appropriate therapeutic interventions, contributing to more targeted and personalized patient care.
The market for molecular diagnostics in infectious diseases is characterized by rapid technological advancements and a growing emphasis on accurate and timely disease detection. Molecular diagnostics involve the identification of pathogens at the molecular level, enabling quicker and more precise diagnosis of infectious diseases. Factors such as the increasing incidence of infectious diseases, demand for point-of-care testing, and advancements in genomics contribute to the market?s expansion. Key players in the industry focus on developing innovative diagnostic platforms and expanding their product portfolios to meet the rising demand for molecular diagnostic solutions. The market is anticipated to experience continuous growth as molecular diagnostics become integral in managing infectious diseases globally, offering benefits such as early detection, personalized treatment strategies, and monitoring of treatment effectiveness.
LP Information, Inc. (LPI) ' newest research report, the ?Molecular Diagnostics for Infectious Diseases Industry Forecast? looks at past sales and reviews total world Molecular Diagnostics for Infectious Diseases sales in 2025, providing a comprehensive analysis by region and market sector of projected Molecular Diagnostics for Infectious Diseases sales for 2026 through 2032. With Molecular Diagnostics for Infectious Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Diagnostics for Infectious Diseases industry.
This Insight Report provides a comprehensive analysis of the global Molecular Diagnostics for Infectious Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Molecular Diagnostics for Infectious Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Molecular Diagnostics for Infectious Diseases market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Diagnostics for Infectious Diseases and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Diagnostics for Infectious Diseases.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Diagnostics for Infectious Diseases market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Molecular diagnostics for infectious diseases involves the detection and analysis of microbial genetic material, such as DNA or RNA, to identify and diagnose infections. This advanced diagnostic approach uses techniques like polymerase chain reaction (PCR), nucleic acid amplification, and gene sequencing to detect the specific genetic signatures of pathogens. Molecular diagnostic tests offer high sensitivity and specificity, enabling the rapid and accurate identification of infectious agents, including bacteria, viruses, fungi, and parasites. These tests play a crucial role in disease diagnosis, monitoring treatment efficacy, and guiding appropriate therapeutic interventions, contributing to more targeted and personalized patient care.
The market for molecular diagnostics in infectious diseases is characterized by rapid technological advancements and a growing emphasis on accurate and timely disease detection. Molecular diagnostics involve the identification of pathogens at the molecular level, enabling quicker and more precise diagnosis of infectious diseases. Factors such as the increasing incidence of infectious diseases, demand for point-of-care testing, and advancements in genomics contribute to the market?s expansion. Key players in the industry focus on developing innovative diagnostic platforms and expanding their product portfolios to meet the rising demand for molecular diagnostic solutions. The market is anticipated to experience continuous growth as molecular diagnostics become integral in managing infectious diseases globally, offering benefits such as early detection, personalized treatment strategies, and monitoring of treatment effectiveness.
LP Information, Inc. (LPI) ' newest research report, the ?Molecular Diagnostics for Infectious Diseases Industry Forecast? looks at past sales and reviews total world Molecular Diagnostics for Infectious Diseases sales in 2025, providing a comprehensive analysis by region and market sector of projected Molecular Diagnostics for Infectious Diseases sales for 2026 through 2032. With Molecular Diagnostics for Infectious Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Diagnostics for Infectious Diseases industry.
This Insight Report provides a comprehensive analysis of the global Molecular Diagnostics for Infectious Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Molecular Diagnostics for Infectious Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Molecular Diagnostics for Infectious Diseases market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Diagnostics for Infectious Diseases and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Diagnostics for Infectious Diseases.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Diagnostics for Infectious Diseases market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Respiratory Tract Infections
- Reproductive Tract Infections
- Blood-borne Infections (BBIs)
- Gastrointestinal Infections (GIIs)
- Other Infections
- Hospital
- Diagnostic Laboratories
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche Diagnostics
- Illumina
- Qiagen
- Abbott Laboratories
- BioM?rieux
- Cepheid (Danaher)
- Thermo Fisher Scientific
- Hologic
- DiaSorin
- Luminex
- Hoffmann-La Roche
- Biocartis
- Nanomix
- BioFire Diagnostics
- Seegene
- QuidelOrtho
- ZeptoMetrix
- Sansure
- BGI Genomics
- DaAn Gene
- Kehua Bio-engineering
- What is the 10-year outlook for the global Molecular Diagnostics for Infectious Diseases market?
- What factors are driving Molecular Diagnostics for Infectious Diseases market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Molecular Diagnostics for Infectious Diseases market opportunities vary by end market size?
- How does Molecular Diagnostics for Infectious Diseases break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Molecular Diagnostics for Infectious Diseases Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Molecular Diagnostics for Infectious Diseases by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Molecular Diagnostics for Infectious Diseases by Country/Region, 2021, 2025 & 2032
2.2 Molecular Diagnostics for Infectious Diseases Segment by Type
2.2.1 Respiratory Tract Infections
2.2.2 Reproductive Tract Infections
2.2.3 Blood-borne Infections (BBIs)
2.2.4 Gastrointestinal Infections (GIIs)
2.2.5 Other Infections
2.2.6 Molecular Diagnostics for Infectious Diseases Sales by Type
2.2.6.1 Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Type (2021-2026)
2.2.6.2 Global Molecular Diagnostics for Infectious Diseases Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Molecular Diagnostics for Infectious Diseases Sale Price by Type (2021-2026)
2.3 Molecular Diagnostics for Infectious Diseases Segment by Application
2.3.1 Hospital
2.3.2 Diagnostic Laboratories
2.3.3 Molecular Diagnostics for Infectious Diseases Sales by Application
2.3.3.1 Global Molecular Diagnostics for Infectious Diseases Sale Market Share by Application (2021-2026)
2.3.3.2 Global Molecular Diagnostics for Infectious Diseases Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Molecular Diagnostics for Infectious Diseases Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Molecular Diagnostics for Infectious Diseases Breakdown Data by Company
3.1.1 Global Molecular Diagnostics for Infectious Diseases Annual Sales by Company (2021-2026)
3.1.2 Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Company (2021-2026)
3.2 Global Molecular Diagnostics for Infectious Diseases Annual Revenue by Company (2021-2026)
3.2.1 Global Molecular Diagnostics for Infectious Diseases Revenue by Company (2021-2026)
3.2.2 Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Company (2021-2026)
3.3 Global Molecular Diagnostics for Infectious Diseases Sale Price by Company
3.4 Key Manufacturers Molecular Diagnostics for Infectious Diseases Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Molecular Diagnostics for Infectious Diseases Product Location Distribution
3.4.2 Players Molecular Diagnostics for Infectious Diseases Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MOLECULAR DIAGNOSTICS FOR INFECTIOUS DISEASES BY GEOGRAPHIC REGION
4.1 World Historic Molecular Diagnostics for Infectious Diseases Market Size by Geographic Region (2021-2026)
4.1.1 Global Molecular Diagnostics for Infectious Diseases Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Molecular Diagnostics for Infectious Diseases Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Molecular Diagnostics for Infectious Diseases Market Size by Country/Region (2021-2026)
4.2.1 Global Molecular Diagnostics for Infectious Diseases Annual Sales by Country/Region (2021-2026)
4.2.2 Global Molecular Diagnostics for Infectious Diseases Annual Revenue by Country/Region (2021-2026)
4.3 Americas Molecular Diagnostics for Infectious Diseases Sales Growth
4.4 APAC Molecular Diagnostics for Infectious Diseases Sales Growth
4.5 Europe Molecular Diagnostics for Infectious Diseases Sales Growth
4.6 Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales Growth
5 AMERICAS
5.1 Americas Molecular Diagnostics for Infectious Diseases Sales by Country
5.1.1 Americas Molecular Diagnostics for Infectious Diseases Sales by Country (2021-2026)
5.1.2 Americas Molecular Diagnostics for Infectious Diseases Revenue by Country (2021-2026)
5.2 Americas Molecular Diagnostics for Infectious Diseases Sales by Type (2021-2026)
5.3 Americas Molecular Diagnostics for Infectious Diseases Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Diagnostics for Infectious Diseases Sales by Region
6.1.1 APAC Molecular Diagnostics for Infectious Diseases Sales by Region (2021-2026)
6.1.2 APAC Molecular Diagnostics for Infectious Diseases Revenue by Region (2021-2026)
6.2 APAC Molecular Diagnostics for Infectious Diseases Sales by Type (2021-2026)
6.3 APAC Molecular Diagnostics for Infectious Diseases Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Molecular Diagnostics for Infectious Diseases by Country
7.1.1 Europe Molecular Diagnostics for Infectious Diseases Sales by Country (2021-2026)
7.1.2 Europe Molecular Diagnostics for Infectious Diseases Revenue by Country (2021-2026)
7.2 Europe Molecular Diagnostics for Infectious Diseases Sales by Type (2021-2026)
7.3 Europe Molecular Diagnostics for Infectious Diseases Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Molecular Diagnostics for Infectious Diseases by Country
8.1.1 Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales by Country (2021-2026)
8.1.2 Middle East & Africa Molecular Diagnostics for Infectious Diseases Revenue by Country (2021-2026)
8.2 Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales by Type (2021-2026)
8.3 Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Molecular Diagnostics for Infectious Diseases
10.3 Manufacturing Process Analysis of Molecular Diagnostics for Infectious Diseases
10.4 Industry Chain Structure of Molecular Diagnostics for Infectious Diseases
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Molecular Diagnostics for Infectious Diseases Distributors
11.3 Molecular Diagnostics for Infectious Diseases Customer
12 WORLD FORECAST REVIEW FOR MOLECULAR DIAGNOSTICS FOR INFECTIOUS DISEASES BY GEOGRAPHIC REGION
12.1 Global Molecular Diagnostics for Infectious Diseases Market Size Forecast by Region
12.1.1 Global Molecular Diagnostics for Infectious Diseases Forecast by Region (2027-2032)
12.1.2 Global Molecular Diagnostics for Infectious Diseases Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Molecular Diagnostics for Infectious Diseases Forecast by Type (2027-2032)
12.7 Global Molecular Diagnostics for Infectious Diseases Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Roche Diagnostics
13.1.1 Roche Diagnostics Company Information
13.1.2 Roche Diagnostics Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.1.3 Roche Diagnostics Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Roche Diagnostics Main Business Overview
13.1.5 Roche Diagnostics Latest Developments
13.2 Illumina
13.2.1 Illumina Company Information
13.2.2 Illumina Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.2.3 Illumina Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Illumina Main Business Overview
13.2.5 Illumina Latest Developments
13.3 Qiagen
13.3.1 Qiagen Company Information
13.3.2 Qiagen Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.3.3 Qiagen Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Qiagen Main Business Overview
13.3.5 Qiagen Latest Developments
13.4 Abbott Laboratories
13.4.1 Abbott Laboratories Company Information
13.4.2 Abbott Laboratories Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.4.3 Abbott Laboratories Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Abbott Laboratories Main Business Overview
13.4.5 Abbott Laboratories Latest Developments
13.5 BioM?rieux
13.5.1 BioM?rieux Company Information
13.5.2 BioM?rieux Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.5.3 BioM?rieux Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 BioM?rieux Main Business Overview
13.5.5 BioM?rieux Latest Developments
13.6 Cepheid (Danaher)
13.6.1 Cepheid (Danaher) Company Information
13.6.2 Cepheid (Danaher) Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.6.3 Cepheid (Danaher) Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Cepheid (Danaher) Main Business Overview
13.6.5 Cepheid (Danaher) Latest Developments
13.7 Thermo Fisher Scientific
13.7.1 Thermo Fisher Scientific Company Information
13.7.2 Thermo Fisher Scientific Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.7.3 Thermo Fisher Scientific Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Thermo Fisher Scientific Main Business Overview
13.7.5 Thermo Fisher Scientific Latest Developments
13.8 Hologic
13.8.1 Hologic Company Information
13.8.2 Hologic Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.8.3 Hologic Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Hologic Main Business Overview
13.8.5 Hologic Latest Developments
13.9 DiaSorin
13.9.1 DiaSorin Company Information
13.9.2 DiaSorin Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.9.3 DiaSorin Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 DiaSorin Main Business Overview
13.9.5 DiaSorin Latest Developments
13.10 Luminex
13.10.1 Luminex Company Information
13.10.2 Luminex Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.10.3 Luminex Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Luminex Main Business Overview
13.10.5 Luminex Latest Developments
13.11 Hoffmann-La Roche
13.11.1 Hoffmann-La Roche Company Information
13.11.2 Hoffmann-La Roche Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.11.3 Hoffmann-La Roche Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Hoffmann-La Roche Main Business Overview
13.11.5 Hoffmann-La Roche Latest Developments
13.12 Biocartis
13.12.1 Biocartis Company Information
13.12.2 Biocartis Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.12.3 Biocartis Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Biocartis Main Business Overview
13.12.5 Biocartis Latest Developments
13.13 Nanomix
13.13.1 Nanomix Company Information
13.13.2 Nanomix Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.13.3 Nanomix Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Nanomix Main Business Overview
13.13.5 Nanomix Latest Developments
13.14 BioFire Diagnostics
13.14.1 BioFire Diagnostics Company Information
13.14.2 BioFire Diagnostics Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.14.3 BioFire Diagnostics Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 BioFire Diagnostics Main Business Overview
13.14.5 BioFire Diagnostics Latest Developments
13.15 Seegene
13.15.1 Seegene Company Information
13.15.2 Seegene Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.15.3 Seegene Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Seegene Main Business Overview
13.15.5 Seegene Latest Developments
13.16 QuidelOrtho
13.16.1 QuidelOrtho Company Information
13.16.2 QuidelOrtho Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.16.3 QuidelOrtho Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 QuidelOrtho Main Business Overview
13.16.5 QuidelOrtho Latest Developments
13.17 ZeptoMetrix
13.17.1 ZeptoMetrix Company Information
13.17.2 ZeptoMetrix Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.17.3 ZeptoMetrix Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 ZeptoMetrix Main Business Overview
13.17.5 ZeptoMetrix Latest Developments
13.18 Sansure
13.18.1 Sansure Company Information
13.18.2 Sansure Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.18.3 Sansure Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Sansure Main Business Overview
13.18.5 Sansure Latest Developments
13.19 BGI Genomics
13.19.1 BGI Genomics Company Information
13.19.2 BGI Genomics Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.19.3 BGI Genomics Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 BGI Genomics Main Business Overview
13.19.5 BGI Genomics Latest Developments
13.20 DaAn Gene
13.20.1 DaAn Gene Company Information
13.20.2 DaAn Gene Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.20.3 DaAn Gene Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 DaAn Gene Main Business Overview
13.20.5 DaAn Gene Latest Developments
13.21 Kehua Bio-engineering
13.21.1 Kehua Bio-engineering Company Information
13.21.2 Kehua Bio-engineering Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.21.3 Kehua Bio-engineering Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Kehua Bio-engineering Main Business Overview
13.21.5 Kehua Bio-engineering Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Molecular Diagnostics for Infectious Diseases Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Molecular Diagnostics for Infectious Diseases by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Molecular Diagnostics for Infectious Diseases by Country/Region, 2021, 2025 & 2032
2.2 Molecular Diagnostics for Infectious Diseases Segment by Type
2.2.1 Respiratory Tract Infections
2.2.2 Reproductive Tract Infections
2.2.3 Blood-borne Infections (BBIs)
2.2.4 Gastrointestinal Infections (GIIs)
2.2.5 Other Infections
2.2.6 Molecular Diagnostics for Infectious Diseases Sales by Type
2.2.6.1 Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Type (2021-2026)
2.2.6.2 Global Molecular Diagnostics for Infectious Diseases Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Molecular Diagnostics for Infectious Diseases Sale Price by Type (2021-2026)
2.3 Molecular Diagnostics for Infectious Diseases Segment by Application
2.3.1 Hospital
2.3.2 Diagnostic Laboratories
2.3.3 Molecular Diagnostics for Infectious Diseases Sales by Application
2.3.3.1 Global Molecular Diagnostics for Infectious Diseases Sale Market Share by Application (2021-2026)
2.3.3.2 Global Molecular Diagnostics for Infectious Diseases Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Molecular Diagnostics for Infectious Diseases Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Molecular Diagnostics for Infectious Diseases Breakdown Data by Company
3.1.1 Global Molecular Diagnostics for Infectious Diseases Annual Sales by Company (2021-2026)
3.1.2 Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Company (2021-2026)
3.2 Global Molecular Diagnostics for Infectious Diseases Annual Revenue by Company (2021-2026)
3.2.1 Global Molecular Diagnostics for Infectious Diseases Revenue by Company (2021-2026)
3.2.2 Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Company (2021-2026)
3.3 Global Molecular Diagnostics for Infectious Diseases Sale Price by Company
3.4 Key Manufacturers Molecular Diagnostics for Infectious Diseases Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Molecular Diagnostics for Infectious Diseases Product Location Distribution
3.4.2 Players Molecular Diagnostics for Infectious Diseases Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MOLECULAR DIAGNOSTICS FOR INFECTIOUS DISEASES BY GEOGRAPHIC REGION
4.1 World Historic Molecular Diagnostics for Infectious Diseases Market Size by Geographic Region (2021-2026)
4.1.1 Global Molecular Diagnostics for Infectious Diseases Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Molecular Diagnostics for Infectious Diseases Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Molecular Diagnostics for Infectious Diseases Market Size by Country/Region (2021-2026)
4.2.1 Global Molecular Diagnostics for Infectious Diseases Annual Sales by Country/Region (2021-2026)
4.2.2 Global Molecular Diagnostics for Infectious Diseases Annual Revenue by Country/Region (2021-2026)
4.3 Americas Molecular Diagnostics for Infectious Diseases Sales Growth
4.4 APAC Molecular Diagnostics for Infectious Diseases Sales Growth
4.5 Europe Molecular Diagnostics for Infectious Diseases Sales Growth
4.6 Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales Growth
5 AMERICAS
5.1 Americas Molecular Diagnostics for Infectious Diseases Sales by Country
5.1.1 Americas Molecular Diagnostics for Infectious Diseases Sales by Country (2021-2026)
5.1.2 Americas Molecular Diagnostics for Infectious Diseases Revenue by Country (2021-2026)
5.2 Americas Molecular Diagnostics for Infectious Diseases Sales by Type (2021-2026)
5.3 Americas Molecular Diagnostics for Infectious Diseases Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Diagnostics for Infectious Diseases Sales by Region
6.1.1 APAC Molecular Diagnostics for Infectious Diseases Sales by Region (2021-2026)
6.1.2 APAC Molecular Diagnostics for Infectious Diseases Revenue by Region (2021-2026)
6.2 APAC Molecular Diagnostics for Infectious Diseases Sales by Type (2021-2026)
6.3 APAC Molecular Diagnostics for Infectious Diseases Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Molecular Diagnostics for Infectious Diseases by Country
7.1.1 Europe Molecular Diagnostics for Infectious Diseases Sales by Country (2021-2026)
7.1.2 Europe Molecular Diagnostics for Infectious Diseases Revenue by Country (2021-2026)
7.2 Europe Molecular Diagnostics for Infectious Diseases Sales by Type (2021-2026)
7.3 Europe Molecular Diagnostics for Infectious Diseases Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Molecular Diagnostics for Infectious Diseases by Country
8.1.1 Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales by Country (2021-2026)
8.1.2 Middle East & Africa Molecular Diagnostics for Infectious Diseases Revenue by Country (2021-2026)
8.2 Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales by Type (2021-2026)
8.3 Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Molecular Diagnostics for Infectious Diseases
10.3 Manufacturing Process Analysis of Molecular Diagnostics for Infectious Diseases
10.4 Industry Chain Structure of Molecular Diagnostics for Infectious Diseases
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Molecular Diagnostics for Infectious Diseases Distributors
11.3 Molecular Diagnostics for Infectious Diseases Customer
12 WORLD FORECAST REVIEW FOR MOLECULAR DIAGNOSTICS FOR INFECTIOUS DISEASES BY GEOGRAPHIC REGION
12.1 Global Molecular Diagnostics for Infectious Diseases Market Size Forecast by Region
12.1.1 Global Molecular Diagnostics for Infectious Diseases Forecast by Region (2027-2032)
12.1.2 Global Molecular Diagnostics for Infectious Diseases Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Molecular Diagnostics for Infectious Diseases Forecast by Type (2027-2032)
12.7 Global Molecular Diagnostics for Infectious Diseases Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Roche Diagnostics
13.1.1 Roche Diagnostics Company Information
13.1.2 Roche Diagnostics Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.1.3 Roche Diagnostics Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Roche Diagnostics Main Business Overview
13.1.5 Roche Diagnostics Latest Developments
13.2 Illumina
13.2.1 Illumina Company Information
13.2.2 Illumina Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.2.3 Illumina Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Illumina Main Business Overview
13.2.5 Illumina Latest Developments
13.3 Qiagen
13.3.1 Qiagen Company Information
13.3.2 Qiagen Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.3.3 Qiagen Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Qiagen Main Business Overview
13.3.5 Qiagen Latest Developments
13.4 Abbott Laboratories
13.4.1 Abbott Laboratories Company Information
13.4.2 Abbott Laboratories Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.4.3 Abbott Laboratories Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Abbott Laboratories Main Business Overview
13.4.5 Abbott Laboratories Latest Developments
13.5 BioM?rieux
13.5.1 BioM?rieux Company Information
13.5.2 BioM?rieux Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.5.3 BioM?rieux Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 BioM?rieux Main Business Overview
13.5.5 BioM?rieux Latest Developments
13.6 Cepheid (Danaher)
13.6.1 Cepheid (Danaher) Company Information
13.6.2 Cepheid (Danaher) Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.6.3 Cepheid (Danaher) Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Cepheid (Danaher) Main Business Overview
13.6.5 Cepheid (Danaher) Latest Developments
13.7 Thermo Fisher Scientific
13.7.1 Thermo Fisher Scientific Company Information
13.7.2 Thermo Fisher Scientific Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.7.3 Thermo Fisher Scientific Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Thermo Fisher Scientific Main Business Overview
13.7.5 Thermo Fisher Scientific Latest Developments
13.8 Hologic
13.8.1 Hologic Company Information
13.8.2 Hologic Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.8.3 Hologic Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Hologic Main Business Overview
13.8.5 Hologic Latest Developments
13.9 DiaSorin
13.9.1 DiaSorin Company Information
13.9.2 DiaSorin Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.9.3 DiaSorin Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 DiaSorin Main Business Overview
13.9.5 DiaSorin Latest Developments
13.10 Luminex
13.10.1 Luminex Company Information
13.10.2 Luminex Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.10.3 Luminex Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Luminex Main Business Overview
13.10.5 Luminex Latest Developments
13.11 Hoffmann-La Roche
13.11.1 Hoffmann-La Roche Company Information
13.11.2 Hoffmann-La Roche Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.11.3 Hoffmann-La Roche Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Hoffmann-La Roche Main Business Overview
13.11.5 Hoffmann-La Roche Latest Developments
13.12 Biocartis
13.12.1 Biocartis Company Information
13.12.2 Biocartis Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.12.3 Biocartis Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Biocartis Main Business Overview
13.12.5 Biocartis Latest Developments
13.13 Nanomix
13.13.1 Nanomix Company Information
13.13.2 Nanomix Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.13.3 Nanomix Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Nanomix Main Business Overview
13.13.5 Nanomix Latest Developments
13.14 BioFire Diagnostics
13.14.1 BioFire Diagnostics Company Information
13.14.2 BioFire Diagnostics Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.14.3 BioFire Diagnostics Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 BioFire Diagnostics Main Business Overview
13.14.5 BioFire Diagnostics Latest Developments
13.15 Seegene
13.15.1 Seegene Company Information
13.15.2 Seegene Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.15.3 Seegene Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Seegene Main Business Overview
13.15.5 Seegene Latest Developments
13.16 QuidelOrtho
13.16.1 QuidelOrtho Company Information
13.16.2 QuidelOrtho Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.16.3 QuidelOrtho Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 QuidelOrtho Main Business Overview
13.16.5 QuidelOrtho Latest Developments
13.17 ZeptoMetrix
13.17.1 ZeptoMetrix Company Information
13.17.2 ZeptoMetrix Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.17.3 ZeptoMetrix Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 ZeptoMetrix Main Business Overview
13.17.5 ZeptoMetrix Latest Developments
13.18 Sansure
13.18.1 Sansure Company Information
13.18.2 Sansure Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.18.3 Sansure Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Sansure Main Business Overview
13.18.5 Sansure Latest Developments
13.19 BGI Genomics
13.19.1 BGI Genomics Company Information
13.19.2 BGI Genomics Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.19.3 BGI Genomics Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 BGI Genomics Main Business Overview
13.19.5 BGI Genomics Latest Developments
13.20 DaAn Gene
13.20.1 DaAn Gene Company Information
13.20.2 DaAn Gene Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.20.3 DaAn Gene Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 DaAn Gene Main Business Overview
13.20.5 DaAn Gene Latest Developments
13.21 Kehua Bio-engineering
13.21.1 Kehua Bio-engineering Company Information
13.21.2 Kehua Bio-engineering Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.21.3 Kehua Bio-engineering Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Kehua Bio-engineering Main Business Overview
13.21.5 Kehua Bio-engineering Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Molecular Diagnostics for Infectious Diseases Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Molecular Diagnostics for Infectious Diseases Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Respiratory Tract Infections
Table 4. Major Players of Reproductive Tract Infections
Table 5. Major Players of Blood-borne Infections (BBIs)
Table 6. Major Players of Gastrointestinal Infections (GIIs)
Table 7. Major Players of Other Infections
Table 8. Global Molecular Diagnostics for Infectious Diseases Sales by Type (2021-2026) & (K Units)
Table 9. Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Type (2021-2026)
Table 10. Global Molecular Diagnostics for Infectious Diseases Revenue by Type (2021-2026) & ($ million)
Table 11. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Type (2021-2026)
Table 12. Global Molecular Diagnostics for Infectious Diseases Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global Molecular Diagnostics for Infectious Diseases Sale by Application (2021-2026) & (K Units)
Table 14. Global Molecular Diagnostics for Infectious Diseases Sale Market Share by Application (2021-2026)
Table 15. Global Molecular Diagnostics for Infectious Diseases Revenue by Application (2021-2026) & ($ million)
Table 16. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Application (2021-2026)
Table 17. Global Molecular Diagnostics for Infectious Diseases Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global Molecular Diagnostics for Infectious Diseases Sales by Company (2021-2026) & (K Units)
Table 19. Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Company (2021-2026)
Table 20. Global Molecular Diagnostics for Infectious Diseases Revenue by Company (2021-2026) & ($ millions)
Table 21. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Company (2021-2026)
Table 22. Global Molecular Diagnostics for Infectious Diseases Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers Molecular Diagnostics for Infectious Diseases Producing Area Distribution and Sales Area
Table 24. Players Molecular Diagnostics for Infectious Diseases Products Offered
Table 25. Molecular Diagnostics for Infectious Diseases Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Molecular Diagnostics for Infectious Diseases Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global Molecular Diagnostics for Infectious Diseases Sales Market Share Geographic Region (2021-2026)
Table 30. Global Molecular Diagnostics for Infectious Diseases Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global Molecular Diagnostics for Infectious Diseases Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Country/Region (2021-2026)
Table 34. Global Molecular Diagnostics for Infectious Diseases Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Molecular Diagnostics for Infectious Diseases Sales by Country (2021-2026) & (K Units)
Table 37. Americas Molecular Diagnostics for Infectious Diseases Sales Market Share by Country (2021-2026)
Table 38. Americas Molecular Diagnostics for Infectious Diseases Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas Molecular Diagnostics for Infectious Diseases Sales by Type (2021-2026) & (K Units)
Table 40. Americas Molecular Diagnostics for Infectious Diseases Sales by Application (2021-2026) & (K Units)
Table 41. APAC Molecular Diagnostics for Infectious Diseases Sales by Region (2021-2026) & (K Units)
Table 42. APAC Molecular Diagnostics for Infectious Diseases Sales Market Share by Region (2021-2026)
Table 43. APAC Molecular Diagnostics for Infectious Diseases Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC Molecular Diagnostics for Infectious Diseases Sales by Type (2021-2026) & (K Units)
Table 45. APAC Molecular Diagnostics for Infectious Diseases Sales by Application (2021-2026) & (K Units)
Table 46. Europe Molecular Diagnostics for Infectious Diseases Sales by Country (2021-2026) & (K Units)
Table 47. Europe Molecular Diagnostics for Infectious Diseases Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe Molecular Diagnostics for Infectious Diseases Sales by Type (2021-2026) & (K Units)
Table 49. Europe Molecular Diagnostics for Infectious Diseases Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa Molecular Diagnostics for Infectious Diseases Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Molecular Diagnostics for Infectious Diseases
Table 55. Key Market Challenges & Risks of Molecular Diagnostics for Infectious Diseases
Table 56. Key Industry Trends of Molecular Diagnostics for Infectious Diseases
Table 57. Molecular Diagnostics for Infectious Diseases Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Molecular Diagnostics for Infectious Diseases Distributors List
Table 60. Molecular Diagnostics for Infectious Diseases Customer List
Table 61. Global Molecular Diagnostics for Infectious Diseases Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global Molecular Diagnostics for Infectious Diseases Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas Molecular Diagnostics for Infectious Diseases Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas Molecular Diagnostics for Infectious Diseases Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC Molecular Diagnostics for Infectious Diseases Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC Molecular Diagnostics for Infectious Diseases Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe Molecular Diagnostics for Infectious Diseases Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe Molecular Diagnostics for Infectious Diseases Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa Molecular Diagnostics for Infectious Diseases Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global Molecular Diagnostics for Infectious Diseases Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global Molecular Diagnostics for Infectious Diseases Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global Molecular Diagnostics for Infectious Diseases Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global Molecular Diagnostics for Infectious Diseases Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. Roche Diagnostics Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 76. Roche Diagnostics Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 77. Roche Diagnostics Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Roche Diagnostics Main Business
Table 79. Roche Diagnostics Latest Developments
Table 80. Illumina Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 81. Illumina Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 82. Illumina Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Illumina Main Business
Table 84. Illumina Latest Developments
Table 85. Qiagen Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 86. Qiagen Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 87. Qiagen Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Qiagen Main Business
Table 89. Qiagen Latest Developments
Table 90. Abbott Laboratories Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 91. Abbott Laboratories Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 92. Abbott Laboratories Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Abbott Laboratories Main Business
Table 94. Abbott Laboratories Latest Developments
Table 95. BioM?rieux Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 96. BioM?rieux Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 97. BioM?rieux Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. BioM?rieux Main Business
Table 99. BioM?rieux Latest Developments
Table 100. Cepheid (Danaher) Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 101. Cepheid (Danaher) Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 102. Cepheid (Danaher) Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Cepheid (Danaher) Main Business
Table 104. Cepheid (Danaher) Latest Developments
Table 105. Thermo Fisher Scientific Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 106. Thermo Fisher Scientific Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 107. Thermo Fisher Scientific Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Thermo Fisher Scientific Main Business
Table 109. Thermo Fisher Scientific Latest Developments
Table 110. Hologic Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 111. Hologic Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 112. Hologic Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Hologic Main Business
Table 114. Hologic Latest Developments
Table 115. DiaSorin Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 116. DiaSorin Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 117. DiaSorin Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. DiaSorin Main Business
Table 119. DiaSorin Latest Developments
Table 120. Luminex Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 121. Luminex Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 122. Luminex Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Luminex Main Business
Table 124. Luminex Latest Developments
Table 125. Hoffmann-La Roche Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 126. Hoffmann-La Roche Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 127. Hoffmann-La Roche Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Hoffmann-La Roche Main Business
Table 129. Hoffmann-La Roche Latest Developments
Table 130. Biocartis Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 131. Biocartis Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 132. Biocartis Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Biocartis Main Business
Table 134. Biocartis Latest Developments
Table 135. Nanomix Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 136. Nanomix Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 137. Nanomix Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. Nanomix Main Business
Table 139. Nanomix Latest Developments
Table 140. BioFire Diagnostics Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 141. BioFire Diagnostics Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 142. BioFire Diagnostics Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. BioFire Diagnostics Main Business
Table 144. BioFire Diagnostics Latest Developments
Table 145. Seegene Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 146. Seegene Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 147. Seegene Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. Seegene Main Business
Table 149. Seegene Latest Developments
Table 150. QuidelOrtho Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 151. QuidelOrtho Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 152. QuidelOrtho Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. QuidelOrtho Main Business
Table 154. QuidelOrtho Latest Developments
Table 155. ZeptoMetrix Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 156. ZeptoMetrix Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 157. ZeptoMetrix Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 158. ZeptoMetrix Main Business
Table 159. ZeptoMetrix Latest Developments
Table 160. Sansure Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 161. Sansure Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 162. Sansure Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 163. Sansure Main Business
Table 164. Sansure Latest Developments
Table 165. BGI Genomics Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 166. BGI Genomics Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 167. BGI Genomics Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 168. BGI Genomics Main Business
Table 169. BGI Genomics Latest Developments
Table 170. DaAn Gene Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 171. DaAn Gene Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 172. DaAn Gene Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 173. DaAn Gene Main Business
Table 174. DaAn Gene Latest Developments
Table 175. Kehua Bio-engineering Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 176. Kehua Bio-engineering Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 177. Kehua Bio-engineering Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 178. Kehua Bio-engineering Main Business
Table 179. Kehua Bio-engineering Latest Developments
Table 1. Molecular Diagnostics for Infectious Diseases Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Molecular Diagnostics for Infectious Diseases Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Respiratory Tract Infections
Table 4. Major Players of Reproductive Tract Infections
Table 5. Major Players of Blood-borne Infections (BBIs)
Table 6. Major Players of Gastrointestinal Infections (GIIs)
Table 7. Major Players of Other Infections
Table 8. Global Molecular Diagnostics for Infectious Diseases Sales by Type (2021-2026) & (K Units)
Table 9. Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Type (2021-2026)
Table 10. Global Molecular Diagnostics for Infectious Diseases Revenue by Type (2021-2026) & ($ million)
Table 11. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Type (2021-2026)
Table 12. Global Molecular Diagnostics for Infectious Diseases Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global Molecular Diagnostics for Infectious Diseases Sale by Application (2021-2026) & (K Units)
Table 14. Global Molecular Diagnostics for Infectious Diseases Sale Market Share by Application (2021-2026)
Table 15. Global Molecular Diagnostics for Infectious Diseases Revenue by Application (2021-2026) & ($ million)
Table 16. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Application (2021-2026)
Table 17. Global Molecular Diagnostics for Infectious Diseases Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global Molecular Diagnostics for Infectious Diseases Sales by Company (2021-2026) & (K Units)
Table 19. Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Company (2021-2026)
Table 20. Global Molecular Diagnostics for Infectious Diseases Revenue by Company (2021-2026) & ($ millions)
Table 21. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Company (2021-2026)
Table 22. Global Molecular Diagnostics for Infectious Diseases Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers Molecular Diagnostics for Infectious Diseases Producing Area Distribution and Sales Area
Table 24. Players Molecular Diagnostics for Infectious Diseases Products Offered
Table 25. Molecular Diagnostics for Infectious Diseases Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Molecular Diagnostics for Infectious Diseases Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global Molecular Diagnostics for Infectious Diseases Sales Market Share Geographic Region (2021-2026)
Table 30. Global Molecular Diagnostics for Infectious Diseases Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global Molecular Diagnostics for Infectious Diseases Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Country/Region (2021-2026)
Table 34. Global Molecular Diagnostics for Infectious Diseases Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Molecular Diagnostics for Infectious Diseases Sales by Country (2021-2026) & (K Units)
Table 37. Americas Molecular Diagnostics for Infectious Diseases Sales Market Share by Country (2021-2026)
Table 38. Americas Molecular Diagnostics for Infectious Diseases Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas Molecular Diagnostics for Infectious Diseases Sales by Type (2021-2026) & (K Units)
Table 40. Americas Molecular Diagnostics for Infectious Diseases Sales by Application (2021-2026) & (K Units)
Table 41. APAC Molecular Diagnostics for Infectious Diseases Sales by Region (2021-2026) & (K Units)
Table 42. APAC Molecular Diagnostics for Infectious Diseases Sales Market Share by Region (2021-2026)
Table 43. APAC Molecular Diagnostics for Infectious Diseases Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC Molecular Diagnostics for Infectious Diseases Sales by Type (2021-2026) & (K Units)
Table 45. APAC Molecular Diagnostics for Infectious Diseases Sales by Application (2021-2026) & (K Units)
Table 46. Europe Molecular Diagnostics for Infectious Diseases Sales by Country (2021-2026) & (K Units)
Table 47. Europe Molecular Diagnostics for Infectious Diseases Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe Molecular Diagnostics for Infectious Diseases Sales by Type (2021-2026) & (K Units)
Table 49. Europe Molecular Diagnostics for Infectious Diseases Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa Molecular Diagnostics for Infectious Diseases Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Molecular Diagnostics for Infectious Diseases
Table 55. Key Market Challenges & Risks of Molecular Diagnostics for Infectious Diseases
Table 56. Key Industry Trends of Molecular Diagnostics for Infectious Diseases
Table 57. Molecular Diagnostics for Infectious Diseases Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Molecular Diagnostics for Infectious Diseases Distributors List
Table 60. Molecular Diagnostics for Infectious Diseases Customer List
Table 61. Global Molecular Diagnostics for Infectious Diseases Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global Molecular Diagnostics for Infectious Diseases Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas Molecular Diagnostics for Infectious Diseases Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas Molecular Diagnostics for Infectious Diseases Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC Molecular Diagnostics for Infectious Diseases Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC Molecular Diagnostics for Infectious Diseases Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe Molecular Diagnostics for Infectious Diseases Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe Molecular Diagnostics for Infectious Diseases Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa Molecular Diagnostics for Infectious Diseases Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global Molecular Diagnostics for Infectious Diseases Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global Molecular Diagnostics for Infectious Diseases Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global Molecular Diagnostics for Infectious Diseases Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global Molecular Diagnostics for Infectious Diseases Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. Roche Diagnostics Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 76. Roche Diagnostics Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 77. Roche Diagnostics Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Roche Diagnostics Main Business
Table 79. Roche Diagnostics Latest Developments
Table 80. Illumina Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 81. Illumina Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 82. Illumina Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Illumina Main Business
Table 84. Illumina Latest Developments
Table 85. Qiagen Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 86. Qiagen Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 87. Qiagen Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Qiagen Main Business
Table 89. Qiagen Latest Developments
Table 90. Abbott Laboratories Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 91. Abbott Laboratories Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 92. Abbott Laboratories Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Abbott Laboratories Main Business
Table 94. Abbott Laboratories Latest Developments
Table 95. BioM?rieux Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 96. BioM?rieux Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 97. BioM?rieux Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. BioM?rieux Main Business
Table 99. BioM?rieux Latest Developments
Table 100. Cepheid (Danaher) Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 101. Cepheid (Danaher) Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 102. Cepheid (Danaher) Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Cepheid (Danaher) Main Business
Table 104. Cepheid (Danaher) Latest Developments
Table 105. Thermo Fisher Scientific Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 106. Thermo Fisher Scientific Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 107. Thermo Fisher Scientific Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Thermo Fisher Scientific Main Business
Table 109. Thermo Fisher Scientific Latest Developments
Table 110. Hologic Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 111. Hologic Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 112. Hologic Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Hologic Main Business
Table 114. Hologic Latest Developments
Table 115. DiaSorin Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 116. DiaSorin Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 117. DiaSorin Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. DiaSorin Main Business
Table 119. DiaSorin Latest Developments
Table 120. Luminex Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 121. Luminex Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 122. Luminex Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Luminex Main Business
Table 124. Luminex Latest Developments
Table 125. Hoffmann-La Roche Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 126. Hoffmann-La Roche Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 127. Hoffmann-La Roche Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Hoffmann-La Roche Main Business
Table 129. Hoffmann-La Roche Latest Developments
Table 130. Biocartis Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 131. Biocartis Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 132. Biocartis Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Biocartis Main Business
Table 134. Biocartis Latest Developments
Table 135. Nanomix Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 136. Nanomix Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 137. Nanomix Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. Nanomix Main Business
Table 139. Nanomix Latest Developments
Table 140. BioFire Diagnostics Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 141. BioFire Diagnostics Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 142. BioFire Diagnostics Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. BioFire Diagnostics Main Business
Table 144. BioFire Diagnostics Latest Developments
Table 145. Seegene Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 146. Seegene Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 147. Seegene Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. Seegene Main Business
Table 149. Seegene Latest Developments
Table 150. QuidelOrtho Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 151. QuidelOrtho Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 152. QuidelOrtho Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. QuidelOrtho Main Business
Table 154. QuidelOrtho Latest Developments
Table 155. ZeptoMetrix Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 156. ZeptoMetrix Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 157. ZeptoMetrix Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 158. ZeptoMetrix Main Business
Table 159. ZeptoMetrix Latest Developments
Table 160. Sansure Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 161. Sansure Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 162. Sansure Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 163. Sansure Main Business
Table 164. Sansure Latest Developments
Table 165. BGI Genomics Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 166. BGI Genomics Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 167. BGI Genomics Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 168. BGI Genomics Main Business
Table 169. BGI Genomics Latest Developments
Table 170. DaAn Gene Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 171. DaAn Gene Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 172. DaAn Gene Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 173. DaAn Gene Main Business
Table 174. DaAn Gene Latest Developments
Table 175. Kehua Bio-engineering Basic Information, Molecular Diagnostics for Infectious Diseases Manufacturing Base, Sales Area and Its Competitors
Table 176. Kehua Bio-engineering Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
Table 177. Kehua Bio-engineering Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 178. Kehua Bio-engineering Main Business
Table 179. Kehua Bio-engineering Latest Developments
LIST OF FIGURES
Figure 1. Picture of Molecular Diagnostics for Infectious Diseases
Figure 2. Molecular Diagnostics for Infectious Diseases Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Molecular Diagnostics for Infectious Diseases Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Molecular Diagnostics for Infectious Diseases Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Molecular Diagnostics for Infectious Diseases Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Molecular Diagnostics for Infectious Diseases Sales Market Share by Country/Region (2025)
Figure 10. Molecular Diagnostics for Infectious Diseases Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Respiratory Tract Infections
Figure 12. Product Picture of Reproductive Tract Infections
Figure 13. Product Picture of Blood-borne Infections (BBIs)
Figure 14. Product Picture of Gastrointestinal Infections (GIIs)
Figure 15. Product Picture of Other Infections
Figure 16. Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Type in 2026
Figure 17. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Type (2021-2026)
Figure 18. Molecular Diagnostics for Infectious Diseases Consumed in Hospital
Figure 19. Global Molecular Diagnostics for Infectious Diseases Market: Hospital (2021-2026) & (K Units)
Figure 20. Molecular Diagnostics for Infectious Diseases Consumed in Diagnostic Laboratories
Figure 21. Global Molecular Diagnostics for Infectious Diseases Market: Diagnostic Laboratories (2021-2026) & (K Units)
Figure 22. Global Molecular Diagnostics for Infectious Diseases Sale Market Share by Application (2025)
Figure 23. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Application in 2026
Figure 24. Molecular Diagnostics for Infectious Diseases Sales by Company in 2026 (K Units)
Figure 25. Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Company in 2026
Figure 26. Molecular Diagnostics for Infectious Diseases Revenue by Company in 2026 ($ millions)
Figure 27. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Company in 2026
Figure 28. Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Molecular Diagnostics for Infectious Diseases Sales 2021-2026 (K Units)
Figure 31. Americas Molecular Diagnostics for Infectious Diseases Revenue 2021-2026 ($ millions)
Figure 32. APAC Molecular Diagnostics for Infectious Diseases Sales 2021-2026 (K Units)
Figure 33. APAC Molecular Diagnostics for Infectious Diseases Revenue 2021-2026 ($ millions)
Figure 34. Europe Molecular Diagnostics for Infectious Diseases Sales 2021-2026 (K Units)
Figure 35. Europe Molecular Diagnostics for Infectious Diseases Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Molecular Diagnostics for Infectious Diseases Revenue 2021-2026 ($ millions)
Figure 38. Americas Molecular Diagnostics for Infectious Diseases Sales Market Share by Country in 2026
Figure 39. Americas Molecular Diagnostics for Infectious Diseases Revenue Market Share by Country (2021-2026)
Figure 40. Americas Molecular Diagnostics for Infectious Diseases Sales Market Share by Type (2021-2026)
Figure 41. Americas Molecular Diagnostics for Infectious Diseases Sales Market Share by Application (2021-2026)
Figure 42. United States Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Molecular Diagnostics for Infectious Diseases Sales Market Share by Region in 2026
Figure 47. APAC Molecular Diagnostics for Infectious Diseases Revenue Market Share by Region (2021-2026)
Figure 48. APAC Molecular Diagnostics for Infectious Diseases Sales Market Share by Type (2021-2026)
Figure 49. APAC Molecular Diagnostics for Infectious Diseases Sales Market Share by Application (2021-2026)
Figure 50. China Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 54. India Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Molecular Diagnostics for Infectious Diseases Sales Market Share by Country in 2026
Figure 58. Europe Molecular Diagnostics for Infectious Diseases Revenue Market Share by Country (2021-2026)
Figure 59. Europe Molecular Diagnostics for Infectious Diseases Sales Market Share by Type (2021-2026)
Figure 60. Europe Molecular Diagnostics for Infectious Diseases Sales Market Share by Application (2021-2026)
Figure 61. Germany Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 62. France Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales Market Share by Application (2021-2026)
Figure 69. Egypt Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Molecular Diagnostics for Infectious Diseases in 2026
Figure 75. Manufacturing Process Analysis of Molecular Diagnostics for Infectious Diseases
Figure 76. Industry Chain Structure of Molecular Diagnostics for Infectious Diseases
Figure 77. Channels of Distribution
Figure 78. Global Molecular Diagnostics for Infectious Diseases Sales Market Forecast by Region (2027-2032)
Figure 79. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Molecular Diagnostics for Infectious Diseases Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Molecular Diagnostics for Infectious Diseases Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Molecular Diagnostics for Infectious Diseases
Figure 2. Molecular Diagnostics for Infectious Diseases Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Molecular Diagnostics for Infectious Diseases Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Molecular Diagnostics for Infectious Diseases Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Molecular Diagnostics for Infectious Diseases Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Molecular Diagnostics for Infectious Diseases Sales Market Share by Country/Region (2025)
Figure 10. Molecular Diagnostics for Infectious Diseases Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Respiratory Tract Infections
Figure 12. Product Picture of Reproductive Tract Infections
Figure 13. Product Picture of Blood-borne Infections (BBIs)
Figure 14. Product Picture of Gastrointestinal Infections (GIIs)
Figure 15. Product Picture of Other Infections
Figure 16. Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Type in 2026
Figure 17. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Type (2021-2026)
Figure 18. Molecular Diagnostics for Infectious Diseases Consumed in Hospital
Figure 19. Global Molecular Diagnostics for Infectious Diseases Market: Hospital (2021-2026) & (K Units)
Figure 20. Molecular Diagnostics for Infectious Diseases Consumed in Diagnostic Laboratories
Figure 21. Global Molecular Diagnostics for Infectious Diseases Market: Diagnostic Laboratories (2021-2026) & (K Units)
Figure 22. Global Molecular Diagnostics for Infectious Diseases Sale Market Share by Application (2025)
Figure 23. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Application in 2026
Figure 24. Molecular Diagnostics for Infectious Diseases Sales by Company in 2026 (K Units)
Figure 25. Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Company in 2026
Figure 26. Molecular Diagnostics for Infectious Diseases Revenue by Company in 2026 ($ millions)
Figure 27. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Company in 2026
Figure 28. Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Molecular Diagnostics for Infectious Diseases Sales 2021-2026 (K Units)
Figure 31. Americas Molecular Diagnostics for Infectious Diseases Revenue 2021-2026 ($ millions)
Figure 32. APAC Molecular Diagnostics for Infectious Diseases Sales 2021-2026 (K Units)
Figure 33. APAC Molecular Diagnostics for Infectious Diseases Revenue 2021-2026 ($ millions)
Figure 34. Europe Molecular Diagnostics for Infectious Diseases Sales 2021-2026 (K Units)
Figure 35. Europe Molecular Diagnostics for Infectious Diseases Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Molecular Diagnostics for Infectious Diseases Revenue 2021-2026 ($ millions)
Figure 38. Americas Molecular Diagnostics for Infectious Diseases Sales Market Share by Country in 2026
Figure 39. Americas Molecular Diagnostics for Infectious Diseases Revenue Market Share by Country (2021-2026)
Figure 40. Americas Molecular Diagnostics for Infectious Diseases Sales Market Share by Type (2021-2026)
Figure 41. Americas Molecular Diagnostics for Infectious Diseases Sales Market Share by Application (2021-2026)
Figure 42. United States Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Molecular Diagnostics for Infectious Diseases Sales Market Share by Region in 2026
Figure 47. APAC Molecular Diagnostics for Infectious Diseases Revenue Market Share by Region (2021-2026)
Figure 48. APAC Molecular Diagnostics for Infectious Diseases Sales Market Share by Type (2021-2026)
Figure 49. APAC Molecular Diagnostics for Infectious Diseases Sales Market Share by Application (2021-2026)
Figure 50. China Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 54. India Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Molecular Diagnostics for Infectious Diseases Sales Market Share by Country in 2026
Figure 58. Europe Molecular Diagnostics for Infectious Diseases Revenue Market Share by Country (2021-2026)
Figure 59. Europe Molecular Diagnostics for Infectious Diseases Sales Market Share by Type (2021-2026)
Figure 60. Europe Molecular Diagnostics for Infectious Diseases Sales Market Share by Application (2021-2026)
Figure 61. Germany Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 62. France Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales Market Share by Application (2021-2026)
Figure 69. Egypt Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Molecular Diagnostics for Infectious Diseases Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Molecular Diagnostics for Infectious Diseases in 2026
Figure 75. Manufacturing Process Analysis of Molecular Diagnostics for Infectious Diseases
Figure 76. Industry Chain Structure of Molecular Diagnostics for Infectious Diseases
Figure 77. Channels of Distribution
Figure 78. Global Molecular Diagnostics for Infectious Diseases Sales Market Forecast by Region (2027-2032)
Figure 79. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Molecular Diagnostics for Infectious Diseases Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Molecular Diagnostics for Infectious Diseases Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Molecular Diagnostics for Infectious Diseases Revenue Market Share Forecast by Application (2027-2032)
